ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] (2022)
Pone, Boniface Kamdem ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: FLAVONOIDES, MEDICAMENTO, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Boniface Kamdem e FERREIRA, Elizabeth Igne. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1389450123666220309093827. Acesso em: 30 set. 2024. , 2022
APA
Pone, B. K., & Ferreira, E. I. (2022). Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/1389450123666220309093827
NLM
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Vancouver
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Artigo de periodico
Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development (2022)
Pone, Kamdem Boniface ; Dalhatou, Sadou; Paumo, Hugues Kamdem ; Seru, Lebogang Maureen Katata ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: TRYPANOSOMA CRUZI, COMPOSTOS HETEROCÍCLICOS, ANTIPROTOZOÁRIOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Kamdem Boniface et al. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, v. 23, n. 1, p. 33-59, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450122666210412125643. Acesso em: 30 set. 2024.
APA
Pone, K. B., Dalhatou, S., Paumo, H. K., Seru, L. M. K., & Ferreira, E. I. (2022). Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, 23( 1), 33-59. doi:10.2174/1389450122666210412125643
NLM
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Vancouver
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Artigo de periodico
Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating (2022)
Soares, Ricardo Oliveira dos Santos; Albuquerque, Agnes Afrodite Sumarelli; Evora, Paulo Roberto Barbosa
Fonte: Current Drug Targets. Unidade: FMRP
Assuntos: ISQUEMIA, ENDOTÉLIO VASCULAR, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Ricardo Oliveira dos Santos e ALBUQUERQUE, Agnes Afrodite Sumarelli e EVORA, Paulo Roberto Barbosa. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating. Current Drug Targets, v. 23, n. 12, p. 1128-1132, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450123666220519170221. Acesso em: 30 set. 2024.
APA
Soares, R. O. dos S., Albuquerque, A. A. S., & Evora, P. R. B. (2022). Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating. Current Drug Targets, 23( 12), 1128-1132. doi:10.2174/1389450123666220519170221
NLM
Soares RO dos S, Albuquerque AAS, Evora PRB. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating [Internet]. Current Drug Targets. 2022 ; 23( 12): 1128-1132.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450123666220519170221
Vancouver
Soares RO dos S, Albuquerque AAS, Evora PRB. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating [Internet]. Current Drug Targets. 2022 ; 23( 12): 1128-1132.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450123666220519170221
Artigo de periodico
The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds (2021)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: DOENÇAS NEGLIGENCIADAS, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, v. 22, p. 379-398, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389450121666201228122239. Acesso em: 30 set. 2024.
APA
Boniface, P. K., & Ferreira, E. I. (2021). The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, 22, 379-398. doi:10.2174/1389450121666201228122239
NLM
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Vancouver
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Artigo de periodico
An insight into the discovery of potent Antifilarial leads against lymphatic filariasis (2020)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: FILARIOSE, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, v. 21, p. 657-680, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450120666191204152415. Acesso em: 30 set. 2024.
APA
Boniface, P. K., & Ferreira, E. I. (2020). An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, 21, 657-680. doi:10.2174/1389450120666191204152415
NLM
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Vancouver
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Artigo de periodico
Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods (2020)
Boniface, Pone Kamdem ; Sano, Cinthya Miyuki; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: LEISHMANIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e SANO, Cinthya Miyuki e FERREIRA, Elizabeth Igne. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, v. 21, p. 681-712, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450121666200128112948. Acesso em: 30 set. 2024.
APA
Boniface, P. K., Sano, C. M., & Ferreira, E. I. (2020). Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, 21, 681-712. doi:10.2174/1389450121666200128112948
NLM
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Vancouver
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Artigo de periodico
Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy (2019)
Oliveira-Paula, Gustavo H.; Tanus-Santos, José Eduardo
Fonte: Current Drug Targets. Unidade: FMRP
Assuntos: HIPERTENSÃO, ÓXIDO NÍTRICO, NITRATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo H. e TANUS-SANTOS, José Eduardo. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, v. 20, n. 4, p. 431-443, 2019Tradução . . Disponível em: https://doi.org/10.2174/1389450119666180816120816. Acesso em: 30 set. 2024.
APA
Oliveira-Paula, G. H., & Tanus-Santos, J. E. (2019). Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, 20( 4), 431-443. doi:10.2174/1389450119666180816120816
NLM
Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450119666180816120816
Vancouver
Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450119666180816120816
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Fonte: Current Drug Targets. Unidades: ICB, FCF, EACH
Assuntos: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 30 set. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Artigo de periodico
The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats (2015)
Cardozo, M. T; Furtado, kelly Silva; De Conti, Aline; Andrade, F. de Oliveira; Fernandes, L. H; Campos, A; Scolastici, C; Moreno, Fernando Salvador
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: CARCINOGÊNESE ANIMAL, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOZO, M. T et al. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats. Current Drug Targets, 2015Tradução . . Disponível em: https://doi.org/10.2174/1389450116666151001110507. Acesso em: 30 set. 2024.
APA
Cardozo, M. T., Furtado, kelly S., De Conti, A., Andrade, F. de O., Fernandes, L. H., Campos, A., et al. (2015). The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats. Current Drug Targets. doi:10.2174/1389450116666151001110507
NLM
Cardozo MT, Furtado kelly S, De Conti A, Andrade F de O, Fernandes LH, Campos A, Scolastici C, Moreno FS. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats [Internet]. Current Drug Targets. 2015 ;[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450116666151001110507
Vancouver
Cardozo MT, Furtado kelly S, De Conti A, Andrade F de O, Fernandes LH, Campos A, Scolastici C, Moreno FS. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats [Internet]. Current Drug Targets. 2015 ;[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1389450116666151001110507
Artigo de periodico
Anticarcinogenic actions of tributyrin,a butyric acid prodrug (2012)
Heidor, Renato ; Ortega, Juliana Festa; Conti, Aline de; Ong, Thomas Prates ; Moreno, Fernando Salvador
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: ANTINEOPLÁSICOS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEIDOR, Renato et al. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets, v. 13, n. 14, p. 1720-1729, 2012Tradução . . Acesso em: 30 set. 2024.
APA
Heidor, R., Ortega, J. F., Conti, A. de, Ong, T. P., & Moreno, F. S. (2012). Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets, 13( 14), 1720-1729.
NLM
Heidor R, Ortega JF, Conti A de, Ong TP, Moreno FS. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets. 2012 ; 13( 14): 1720-1729.[citado 2024 set. 30 ]
Vancouver
Heidor R, Ortega JF, Conti A de, Ong TP, Moreno FS. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets. 2012 ; 13( 14): 1720-1729.[citado 2024 set. 30 ]

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em